Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of venlafaxine prolonged-release capsules 150 mg in healthy Thai volunteers under fasting conditions
TCTR20240427005Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of venlafaxine in major depressive disorder (MDD) (2 arms), sponsored by Bio-innova. Status: unknown.
02
Drugs
venlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on TCTR20240427005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240427005.